Question 12458 — diseases

Summary

Mr. Arthur Delaporte draws the attention of the Minister for Europe and Foreign Affairs to the necessary French contribution to the global fund to fight HIV, tuberculosis and malaria. France has made the fight against these three pandemics a priority of its global health strategy and ranks behind the United States of America. The effectiveness of this fund is widely demonstrated by historical results : for tuberculosis, between 2000 and 2023, mortality fell by 47.9%. In 2023, 7.1 million people could be treated. For HIV/AIDS, since 2010, the number of infections has decreased by a third. In 2023, the fund will make it possible to provide treatment to 25 million people. For malaria, between 2000 and 2023, 12.7 million deaths were avoided worldwide. In 2023 alone, 171 million people were treated and 227 Millions of mosquito nets have been distributed. However, these decades of progress are today threatened by the decline in international funding and cuts in official development assistance. While France had committed 1.596 billion euros during the previous reconstitution, no contribution was announced during the conference of November 21, 2025, marking an unprecedented break since 2002. This lack of commitment poses a vital risk to 2 million people and threatens global health security through a possible resurgence of these diseases. Consequently, he questions him about the amount of the French contribution to the global fund and solemnly calls on him to announce funding at least equal to that of 2022 in order to continue to save lives and respect France's international commitments.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.